
The counter had a total traded volume of 01:27PM shares so far with a turnover of Rs 14.24 crore on BSE. The stock traded at a price-to-earnings multiple of 10.4 and a price-to-book ratio of 1.44.
A higher price-to-earnings ratio shows investors are willing to pay a higher price for per rupee earnings given by the stock because of better future growth expectations.
Did you Know?
Stock score of Aurobindo Pharma Ltd moved down by 2 in 3 months on a 10-point scale.
View Latest Stock Report »The price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Aurobindo Pharma Ltd. belongs to the Pharma - Indian industry.
Promotor/FII Holding
Key Financials
The company reported consolidated net sales of Rs 6079.6 crore for the quarter ended 31-Mar-2021, down 6.44 per cent from the previous quarter's Rs 6498.31 crore and down 1.8 per cent from the year-ago quarter's Rs 6191.02 crore.
Its profit for the latest quarter stood at Rs 801.58 crore, down 5.68 per cent from the same quarter a year ago.
Download The Economic Times News App to get Daily Market Updates & Live Business News.